USB
50
3
MPC
28
3
ADBE
50
3
PDCO
77
3
HES
49
2
DTE
49
16
CCL
68
6
CTSH
55
3
EMC
30
-26
PEP
33
4
NRG
32
5
NOV
45
2
AIG
38
5
ORLY
48
3
SWK
53
4
INTC
35
4
T
32
2
QRVO
16
-6
AMGN
42
14
SCHW
40
3
USB
50
3
MPC
28
3
ADBE
50
3
PDCO
77
3
HES
49
2
DTE
49
16
CCL
68
6
CTSH
55
3
EMC
30
-26
PEP
33
4
NRG
32
5
NOV
45
2
AIG
38
5
ORLY
48
3
SWK
53
4
INTC
35
4
T
32
2
QRVO
16
-6
AMGN
42
14
SCHW
40
3
Financhill
Back

Reviva Pharmaceuticals Holdings 10K Form

Sell
28

RVPH
Reviva Pharmaceuticals Holdings

Last Price:
$1.34
Seasonality Move:
-10.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RVPH News And Ratings

See the #1 stock for the next 7 days that we like better than RVPH

RVPH Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-4.2M
Price / Cash Flow: 0
Annual Sales: $-0.30
Price / Book: 0

Profitability

EPS (TTM): -1.09000
Net Income (TTM): $-33M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Reviva Pharmaceuticals Holdings Earnings Forecast

Key Reviva Pharmaceuticals Holdings Financial Ratios

  • The Interest Expense is -0.03% of Operating Income.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Reviva Pharmaceuticals Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RVPH
Website: revivapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RVPH Technical Analysis vs Fundamental Analysis

Sell
28
Reviva Pharmaceuticals Holdings (RVPH) is a Sell

Is Reviva Pharmaceuticals Holdings a Buy or a Sell?